The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Ocular Therapeutix, Inc(NASDAQ:OCUL) 
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel platform technology. The company markets ReSure Sealant, an ophthalmic device designed to prevent...
Website: http://www.ocutx.com
Founded: 2006
Full Time Employees: 161
CEO: Antony Mattessich
Sector: Healthcare
Industry: Biotechnology
Ocular Therapeutix Number of Twitter Followers
Ocular Therapeutix Days Payable Outstanding ttm (DPO)
Ocular Therapeutix Days Receivable Outstanding ttm (DSO)
Ocular Therapeutix Days Inventory Outstanding ttm (DIO)
Ocular Therapeutix Op Cashflow Per Share ttm
Ocular Therapeutix Free Cashflow Per Share ttm
Ocular Therapeutix Cash Per Share ttm
Ocular Therapeutix P/S ratio ttm
Ocular Therapeutix (GAAP) P/E ratio ttm
Ocular Therapeutix P/B ratio ttm
No extra charts and metrics for this ticker.